14 mg rybelsus to wegovy

Published: 2026-06-26

Switching from 14 mg Rybelsus to Wegovy means moving from oral to injectable semaglutide — the same drug — but there is no direct milligram conversion.

Switching from 14 mg Rybelsus to Wegovy means moving from oral semaglutide to injectable semaglutide — the same active drug in a different form, with weight loss as the licensed purpose. Because the formulations and doses differ, there is no simple one-to-one swap: the change must be made by a clinician, who will choose the right starting dose of Wegovy rather than matching the milligrams directly.

Both medicines contain semaglutide, so the goal of a switch is usually to access the higher, weight-loss-licensed dosing that the injectable form provides. Understanding how they compare makes the reasoning clear.

The same drug, different forms

Semaglutide is the active ingredient in both Rybelsus and Wegovy. It works as a glucagon-like peptide-1 (GLP-1) receptor agonist, regulating blood sugar and reducing appetite. The key difference is delivery: Rybelsus is a daily oral tablet, while Wegovy is a once-weekly injection. These different formulations affect how the drug is absorbed and dosed, which is why their milligram numbers are not directly comparable.

Why people switch

The most common reason to move from 14 mg Rybelsus (the highest standard oral dose) to Wegovy is to pursue weight loss with a form that is specifically licensed and dosed for it. Wegovy is titrated up to a higher weight-management dose than oral Rybelsus typically provides, which can mean greater weight loss for suitable patients. The decision still depends on individual health, tolerance and goals.

There is no direct dose conversion

It is a mistake to assume that 14 mg of oral Rybelsus equals a particular dose of Wegovy. Because absorption differs between a swallowed tablet and an injection, the doses are not interchangeable on a milligram basis. Instead, a clinician starts Wegovy at its own low introductory dose and titrates upward over weeks to limit side effects. Trying to match the numbers yourself is both pointless and unsafe.

Side effects when switching

Because it is the same drug, the side-effect profile is similar — chiefly gastrointestinal effects such as nausea, which tend to appear or return when the dose changes and usually settle with time. Switching forms means restarting the gradual titration, so a temporary increase in these effects is normal. For a fuller account of the drug itself, see our article on semaglutide, and for the comparison externally, this overview of semaglutide forms and uses.

Making the change safely

Any switch from Rybelsus to Wegovy should be planned with a healthcare provider, who will set the correct starting dose, manage the titration and check it suits your health. For context on how well the oral form performs, see our article on whether Rybelsus is a good weight loss pill, and for the full picture, our guide to Rybelsus and semaglutide.